SEC Form 4 · accession 0001567619-18-002343
STRATA Skin Sciences, Inc. · SSKN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dolev Rafaeli
Officer — CEO · Director
Period of report
Jun 15, 2018
Accepted (ET)
Sep 10, 2018 · 10:58 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001051514
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| SSKN Common StockF1 | Jun 15, 2018 | J | 5,814 | $1.09 | A | 5,814 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F16/15/18 reporting person was entitled to receive 5,814 shares of common stock pursuant to a "retained risk" provision in the Subscription Agreement & related stock purchase agreement between the Company & the reporting person dated 5/29/18 ("Subscription Agreement"). Subscription Agreement provided that [Purchasers] would receive [additional] shares of common stock in the event of certain contingent expense events, one of which was determined to have occurred 6/15/18, resulted in the purchasers, including the reporting person, acquired additional shares. The number of shares issuable pursuant to that provision, determined on 6/15/18 pursuant to a formula set forth in the Subscription Agreement, provided that, for purposes of determining the number of shares issuable, the common stock would be valued at $1.09 per share, which was the purchase price of the common stock in the Subscription Agreement.